Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference
June 06 2017 - 4:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Tibor
Keler, Ph.D., Co-founder, Executive Vice President and Chief
Scientific Officer, and Thomas Davis, M.D., Executive Vice
President and Chief Medical Officer, will participate in a fireside
chat at the Jefferies 2017 Global Healthcare Conference on June 8,
2017 at 11:00 a.m. EDT in New York.
The live webcast will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for seven days
following the event.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline includes antibodies, antibody-drug conjugates and
other protein-based therapeutics derived from a broad set of
complementary technologies which have the ability to engage the
human immune system and/or directly inhibit tumors to treat
specific types of cancer or other diseases. Visit
www.celldex.com.
Company Contact
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Associate Director of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3107
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024